Key findings
- During this reporting period, 2,883 people across Australia participated in the TraX study and provided at least one follow-up response.
- Throughout the study, monthly rates of testing for mpox remained consistent at approximately 1.0%.
- At study entry, 22.2% of participants reported being unvaccinated against mpox, 50.2% had received one vaccination, and 27.6% had received two mpox vaccinations.
- As of 22 October 2023, the proportion of people who reported being unvaccinated against mpox had reduced by more than half to 9.2%, leaving 266 participants unvaccinated. The proportion who reported having received only one mpox vaccination also fell to 11.0% and the proportion who had received both mpox vaccinations increased to 79.7%.
- At study entry, 12 participants reported prior mpox infection. No new mpox infections were reported throughout the study period.
